Literature DB >> 8438255

Loss of heparan sulfate proteoglycan as a manifestation of cellular immunity in vivo and in vitro.

R L Geller1, N S Ihrcke, J Maines, B J Lindman, J L Platt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8438255

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.

Authors:  S Pillarisetti; L Paka; J C Obunike; L Berglund; I J Goldberg
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Salubrious effect of low molecular weight heparin on atherogenic diet-induced cardiac, hepatic and renal lipid peroxidation and collapse of antioxidant defences.

Authors:  P R Deepa; P Varalakshmi
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

3.  The preventive effects of heparin-superoxide dismutase on carbon tetrachloride-induced acute liver failure and hepatic fibrosis in mice.

Authors:  Jinfeng Liu; Haining Tan; Yongfu Sun; Shuai Zhou; Jichao Cao; Fengshan Wang
Journal:  Mol Cell Biochem       Date:  2009-02-26       Impact factor: 3.396

4.  Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth.

Authors:  Roland El Ghazal; Xin Yin; Scott C Johns; Lee Swanson; Monica Macal; Pradipta Ghosh; Elina I Zuniga; Mark M Fuster
Journal:  Neoplasia       Date:  2016-05       Impact factor: 5.715
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.